TNFSF10 and urinary bladder carcinoma: Combined usage of bufalin and TRAIL can markedly inhibit the viability of human bladder carcinoma cells, sensitizing the TRAIL-resistant bladder carcinoma cells to TRAIL-mediated apoptosis.